Last updated: 2026-09-23 11:38:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $183,57, with a market capitalization of $11,63B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $101,00 to $247,49. This page covers its latest market performance, valuation, price trends and company information.
$11,63B | |
$182,98 | |
$247,49 | |
$10,22 | |
$183,72 | |
22,00 | |
832,36K | |
-- | |
$247,49 | |
$101,00 | |
-- | |
-- |
DaVita Inc. (DVA) is trading at $183,57 in pre-market trading as of 2026-09-23 11:02:00, down 0,08% ($0,15) from the previous close of $183,72
Pre-market trading shows how investors are pricing DVA before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, DaVita Inc. (DVA) moved from $189,32 to $183,57, representing a decline of 3,04% ($5,75).
The stock traded between $181,27 and $195,75 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 945,15 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 56,4%
DVA is currently trading at $183,57, placing it 56,4% of the way from its 52-week low of $101,00 to its 52-week high of $247,49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.